Example of alemtuzumab concentrations in a patient treated with subcutaneous antibody. After an initial dose escalation, 30 mg of alemtuzumab was administered 3 times a week for 12 weeks (). Serum samples were taken before the dose, once a week (▵). This patient made a good clinical response to the therapy and achieved relatively high concentrations of antibody.